The short answer: a topical CBD product is meant to act where you put it, on the skin and the tissue just beneath it. A transdermal product is a specific, engineered delivery system designed to carry a compound through the skin and into the bloodstream, so it can act throughout the body. The word “transdermal” on a label doesn’t mean a product was built or tested that way. That distinction is worth sorting out before trusting any claim that compares the two.
What “Topical” and “Transdermal” Actually Mean
- Topical: Applied to the surface of the skin and intended to act locally, without needing to reach the rest of the body in a meaningful amount.
- Transdermal: A delivery system specifically engineered and tested to move a compound through the skin barrier and into the bloodstream, producing an effect body-wide. Nicotine patches and certain prescription pain patches are familiar examples of this category, built and studied for that purpose.
- Using the word “transdermal” in marketing does not make a product a transdermal delivery system. The FDA has approved exactly one CBD product of any kind, a prescription oral medicine for specific seizure disorders. No CBD topical or patch currently carries that kind of approval or published absorption data, so each one needs to be checked on its own rather than assumed to work the way the category name implies.
Can an Oral Study Support a Topical Claim?
Not on its own. Route of administration, whether a product is swallowed, applied to the skin, or delivered through an engineered transdermal system, changes how much of a compound reaches the bloodstream and where it acts. The FDA’s consumer update on CBD lists this directly among the things that aren’t yet known, naming “how different methods of consumption affect intake (e.g., oral consumption, topical, smoking or vaping)” as an open question. The same update raises a related point: if someone eats CBD-infused food and also uses a CBD skin cream, how much CBD does the cream itself actually contribute? The agency does not have that answer, which means a seller can’t either, no matter how the product is marketed.
In plain terms: a study where people swallowed CBD capsules does not tell you what a cream rubbed on the skin does, and the reverse is also true. For the fuller reasoning behind this, including how formulation and the specific outcome measured also affect whether a cited study actually supports a product’s claim, see our companion piece on why route and formulation matter before comparing any CBD product to a cited study. This page focuses specifically on telling a topical product apart from a true transdermal one before you get to that comparison.
A Cannabis Terminology Worksheet for This Decision
Use this to identify what category a specific product actually falls into before reading any claim on its label.
- CBD topical (cream, balm, salve, roll-on)
- Product form: Applied to the skin; intended to stay local to that area.
- Cannabinoid named on label: Usually listed as “CBD” or “full spectrum hemp extract”; labels often don’t disclose whether penetration-enhancing ingredients are included.
- Legal/safety question to ask: Does the label or sales page claim the product treats, cures, or prevents a disease? Under FDA rules, an unapproved CBD product cannot legally make that kind of claim.
- Relevant source and date: FDA Consumer Update on cannabis and CBD products, content current as of March 5, 2020.
- What remains unknown: How much of the labeled CBD, if any, actually reaches the bloodstream from that specific formulation.
- Transdermal patch
- Product form: An adhesive patch marketed as delivering a compound through the skin into systemic circulation.
- Cannabinoid named on label: Varies by product. No CBD transdermal patch currently has FDA approval, so “transdermal” on the package is a marketing description, not confirmation that absorption has been measured for that product.
- Legal/safety question to ask: Is there any published, product-specific data showing this item actually delivers CBD into the bloodstream, or is “transdermal” being used as a category name without supporting data?
- Relevant source and date: Same FDA update above.
- What remains unknown: Whether the specific product on the shelf has ever been tested for how much CBD it delivers into the body, if any.
- Oral CBD (capsule, swallowed tincture, gummy)
- Product form: Swallowed, absorbed through the digestive tract, and processed by the liver before reaching general circulation.
- Cannabinoid named on label: Typically a stated CBD amount per serving. Federal testing cited by the National Institute on Drug Abuse has found that some products marketed as CBD contained different amounts of CBD than their labels stated, and some contained THC not listed on the label.
- Legal/safety question to ask: Have you checked with a clinician if you take other medications? The FDA’s review of its approved oral CBD drug identified liver-injury and drug-interaction risks that informed its broader CBD safety guidance.
- Relevant source and date: FDA Consumer Update, March 5, 2020; NIDA cannabis research overview.
- What remains unknown: What happens with sustained daily use over time, and what level of intake triggers the known risks. The FDA lists both as open questions for CBD generally, regardless of route.
What This Means for a Reader Comparing Products
Before trusting a claim that compares these categories, it helps to ask: What route was actually studied? Is that the same route as the product in front of me? And does the label make any disease-related claim that federal rules don’t currently allow for an unapproved CBD product? If you take prescription medication or have an existing health condition, the FDA’s position is that CBD use of any kind, topical, transdermal, or oral, should be discussed with a healthcare provider first.
Where This Fits With Our Other CBD Coverage
This page answers one specific question: what separates a topical product from a true transdermal one, and why a study on one route can’t be assumed to cover the other. It’s a companion to our Golden Touch Fusion CBD Gummies complaints and refund guide, which covers billing, refund timelines, and product-specific safety information for one oral gummy, not the delivery-route question addressed here. For the full method of checking whether any cited study actually supports a specific product’s claim, including formulation and outcome matching, see why route and formulation matter before you compare a gummy. If you’re trying to separate a billing complaint from an actual health claim on a seller’s page, our guide to reading CBD complaint pages covers that distinction.
By MedClinRes.org Editorial Team
This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.